Iovance Biotherapeutics PEG Ratio

Iovance Biotherapeutics (IOVA) currently reports a PEG ratio of 13.84. That is above the Healthcare sector average of 11.64. Use the charts on this page to explore Iovance Biotherapeutics's PEG ratio history and peer comparisons.

Iovance Biotherapeutics's PEG ratio of 13.84 is higher than the Healthcare sector average of 11.64. That is roughly 18.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Iovance Biotherapeutics's market price to a fundamental measure such as earnings, sales, or book value. At 13.84, IOVA can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 13.84, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.64. From there, open related valuation or income-statement pages for Iovance Biotherapeutics, and consider following IOVA for alerts when major investors trade the stock.

Iovance Biotherapeutics is classified in the Healthcare sector. On PEG ratio, it currently shows 13.84 versus a sector average near 11.64. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IOVA with unrelated industries.